Literature DB >> 15718036

Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.

Ilaria Guidi1, Daniela Galimberti, Eliana Venturelli, Carlo Lovati, Roberto Del Bo, Chiara Fenoglio, Alberto Gatti, Roberto Dominici, Sara Galbiati, Roberta Virgilio, Simone Pomati, Giacomo P Comi, Claudio Mariani, Gianluigi Forloni, Nereo Bresolin, Elio Scarpini.   

Abstract

The distribution of the Glu298Asp polymorphism in NOS3 gene was determined in 405 Italian patients with "probable" Alzheimer's disease (AD) compared with 253 age-matched controls. Total plasma homocysteine (tHcy) levels were evaluated in 97 patients and 23 controls, and were correlated with the Glu298Asp genotype. A significantly increased frequency of the Glu/Glu genotype in late onset AD (LOAD) patients was found. tHcy levels were significantly increased in patients compared with controls and, notably, higher in LOAD than in early onset AD (EOAD). Stratifying by the Glu298Asp genotype, a trend toward an increase of tHcy was present in Glu/Glu homozygous. This wild type genotype seems to be associated with LOAD. tHcy levels are significantly increased in AD compared with controls and, moreover, higher in LOAD than in EOAD, possibly in correlation with the microvascular disease occurring with aging. Besides, a contribution of the Glu/Glu genotype in increasing tHcy levels has been observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718036     DOI: 10.1016/j.neurobiolaging.2004.07.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

Review 1.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

2.  The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.

Authors:  Nadia Ferlazzo; Gaetano Gorgone; Daniela Caccamo; Monica Currò; Salvatore Condello; Francesco Pisani; Fabrizio Vernieri; Paolo Maria Rossini; Riccardo Ientile
Journal:  Neuromolecular Med       Date:  2011-05-24       Impact factor: 3.843

3.  APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

Authors:  Carlo Lovati; Daniela Galimberti; Diego Albani; Pierluigi Bertora; Eliana Venturelli; Giuliana Cislaghi; Ilaria Guidi; Chiara Fenoglio; Francesca Cortini; Francesca Clerici; Dario Finazzi; Gianluigi Forloni; Elio Scarpini; Claudio Mariani
Journal:  Int J Mol Epidemiol Genet       Date:  2010-04-05

4.  Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Int J Clin Exp Med       Date:  2010-05-15

5.  Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism in Chinese.

Authors:  Binbin Wang; Sainan Tan; Ze Yang; Yan-Chen Xie; Jing Wang; Sirui Zhou; Shu Li; Chenguang Zheng; Xu Ma
Journal:  J Mol Neurosci       Date:  2008-01-09       Impact factor: 3.444

6.  Nitride oxide synthase 3 and klotho gene polymorphisms in the pathogenesis of chronic kidney disease and age-related cognitive impairment: a systematic review and meta-analysis.

Authors:  Atma Gunawan; Jonny Karunia Fajar; Fredo Tamara; Aditya Indra Mahendra; Muhammad Ilmawan; Yeni Purnamasari; Dessy Aprilia Kartini; Eden Suryoiman Winoto; Efriko Septananda Saifillah; Dewi Sri Wulandari; Pratista Adi Krisna; Ema Dianita Mayasari; Tri Wahyudi Iman Dantara; Ramadi Satryo Wicaksono; Djoko Wahono Soeatmadji
Journal:  F1000Res       Date:  2020-04-09

7.  Age-specific epigenetic drift in late-onset Alzheimer's disease.

Authors:  Sun-Chong Wang; Beatrice Oelze; Axel Schumacher
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

8.  The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis.

Authors:  Shengyuan Liu; Fangfang Zeng; Changyi Wang; Zhongwei Chen; Bin Zhao; Keshen Li
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.